(Q42598604)

3 November 2017

Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance (English)

1 reference

3 November 2017

1 reference

1 reference

5

J C Imperial

0 references

author name string

D Bhattacharya

1

1 reference

3 November 2017

D Katzenstein

2

1 reference

3 November 2017

A Wong

3

1 reference

3 November 2017

D Israelski

4

1 reference

3 November 2017

E B Keeffe

6

1 reference

3 November 2017

R M Donovan

7

1 reference

3 November 2017

language of work or name

1 reference

1 November 2008

1 reference

International Journal of STD & AIDS

3 November 2017

1 reference

3 November 2017

19

1 reference

3 November 2017

11

1 reference

3 November 2017

780-781

1 reference

The immunology of hepatitis B.

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914094

16 August 2018

Identifiers

DOI

10.1258/IJSA.2008.008020

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

18931274

1 reference